01:42 PM EDT, 08/09/2024 (MT Newswires) -- ARS Pharmaceuticals ( SPRY ) said Friday that the US Food and Drug Administration has approved neffy 2 mg, an epinephrine nasal spray, to treat Type I allergic reactions, including anaphylaxis, in adults and children weighing at least 30 kilograms. In a statement, the FDA said neffy is the first approved epinephrine product...

On Friday, the FDA approved ARS Pharmaceuticals Inc’s neffy (epinephrine nasal spray) for the emergency treatment of allergic reactions (Type I), including those that are life-threatening (anaphylaxis), for adult and pediatric patients. ARS Pharma’s Neffy is to be an alternative to EpiPen and other autoinjectors like Sanofi SA’s  Auvi-Q filled with epinephrine. The approval comes almost two months before the PDUFA...

01:32 PM EDT, 08/09/2024 (MT Newswires) -- Beatriz R Perez, Executive Vice President, on August 08, 2024, sold 35,382 shares in Coca Cola (KO) for $2,427,984. Following the Form 4 filing with the SEC, Perez has control over a total of 190,070 shares of the company, with 167,107 shares held directly and 22,963 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/21344/000112760224021929/xslF345X03/form4.xml Price: 68.72,...

Editor’s note: This story has been updated to correct Blink Charging’s second-quarter adjusted earnings per share figure to a loss of 18 cents. Benzinga apologizes for the error. Blink Charging Co ( BLNK ) reported its second-quarter financial results Wednesday after the bell. Here’s a rundown of the print. Q2 Earnings: Blink reported second-quarter revenue of $33.26 million, missing analyst...